Government red tape would strangle patient access to medication

Published



Earlier this month, Rep. Frank Pallone, a New Jersey Democrat, introduced a bill that could restrict the Food and Drug Administration’s “accelerated approval” pathway — the program responsible for bringing promising medicines to patients years ahead of schedule.

The accelerated approval pathway is a rare example of government working efficiently. Ensnaring it in red tape is senseless — and could delay patient access to lifesaving treatments.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.